SmartGateVC announces investment in Vonova, advancing catheter-based brain interface technology.
Summary
SmartGateVC is thrilled to announce its investment in Vonova, a groundbreaking medtech company developing a minimally invasive intracranial access platform for the brain interface market. Vonovas innovative approach offers a less invasive alternative to traditional brain surgeries, paving the way for transformative neuromodulation therapies.Ashot Arzumanyan, Partner at SmartGateVC, said, "The marriage of our bodies with AI is a significant emerging area. The company has secured a collaboration agreement with Lawrence Livermore National Laboratory (LLNL) to prototype their electrode array for future product indications using exclusive manufacturing technology, previously utilized in the original Neuralink prototype.Vonovas management team has expertise in catheter device development and neurology. To accelerate product development ahead of a planned priced round, Vonova has opened a convertible note up to $1 million, with SmartGateVC leading the initial investment. This final angel round closes on September 15th, 2024.SmartGateVC is a California and Armenia-based pre-seed/seed venture capital firm backed by seasoned tech investors, entrepreneurs, and professionals.